The federal government could soon be paying for the early manufacturing of potential coronavirus drugs while those drugs are still being researched, under a $10 billion proposal by U.S. Sen. Steve Daines.
The proposal, which received mention on the Sunday news program “Face The Nation” and in the Wall Street Journal, would have the federal government paying for early drug manufacturing so that drugs tested for effectiveness treating coronavirus would be immediately available once determined to work by Food and Drug Administration.